Abstract
T FH cells are present in SLE patients. T FH cells are being evaluated as therapeutic target for SLE [1, 2] . T FH -like cells that express Bcl6, PD1, ICOS and produce IL-21 are present both in ectopic germinal centers (GCs) and lymphoid aggregates [3] . Three subsets of T FH cells are recognized and expression of Bcl6 in circulating T FH cells is debatable [4] [5] [6] .
Ectopic GCs are observed in nephritic kidney in SLE, which show abundance of ICs and complement deposits. The evidence that ICs may play a critical role in GC reaction comes from many previous studies. In GCs, FDCs, macrophages and B cells retain ICs on the cell surface and fulfils the constant antigenic requirement for T FH cell development [7] . Subcapsular sinus (SCS) macrophages retain intact ICs on the cell surface, and transfer these intact ICs to the follicular B cells. Cognate B cells upon capturing ICs migrate to the T cells zones [8, 9] . B cells then scan FDC processes for ICs and upon acquiring ICs from FDCs, they make a contact with T FH cells before moving to GC reaction phase [10] . B cells capture ICs from the macrophages via complement receptors (CRs) and facilitate their transport to FDCs [9] . These studies suggest a key role for ICs in the GC reaction. A role for CRs in the proposed IC transfers is suggested, however a role for Fc receptors (FcRs) in these IC transfers is not excluded. In tightly packed lymphoid follicles, ICs transfer occur from a non-cognate antigen transporting B cells to antigen specific cognate B cells [9] . Furthermore, a non-cognate transport of ICs from B cells to FDCs also occurs [11] . A role for
FcgRIIIa costimulation in naïve/memory cells and ICs bound to T FH cells surface in the GCs
reaction is important area of investigation for the better understanding of autoimmune pathology.
T FH cells upon reaching GCs, trigger T FH -GC B cell interactions, which establishes serological memory [10, 12] . Costimulatory proteins i.e. CD40L-CD40, ICOS-ICOSL, accessory molecules OX40-OX40L, as well as cytokines and their receptors in particular IL4-IL4R, IFN-g-IFN-gR, IL21-IL21R and SAP-SLAM are protein pairs that contribute to the T FH -GC B cell interactions [12] . The disruption of these interaction in SLE mouse models ameliorate disease.
We report that the circulating T FH 
Materials and Methods:
ICs and C5b-9
ICs were purified from 50 ml of pooled serum or plasma from five to ten SLE patients with high levels of complement opsonized ICs. The purification procedures for ICs and C5b-9 have been previously described [13] [14] [15] . The nature of the ICs was characterized for binding to FcgR using cells that express this receptor and compared with aggregated human g-globulin (AHG) and antiFcgRIIIa antibody (clone 3G8) [16] . In addition, ICs were tested for their potential to activate CD4 + T-cells and compared with in vitro formed Ova-anti-Ova ICs in an earlier study [13] .
T cell isolation and Activation
Blood was collected with informed consent in the Saint Louis University Rheumatology clinic. The
PBMCs were isolated using Histopaque gradient (Sigma). PBMCs were isolated within 12 h of sample collection and monocytes were removed by overnight plating in a culture dish. The next day, the CD4 + CD45RA + cells were purified using naïve CD4 + T-cell isolation kit II (product no. 130-094-131, Miltenyi Biotec). Purified naïve CD4 + T-cells represented a >97% pure population.
Purified cells were maintained in culture with 20 U of IL-2 for two days. Thereafter, these cells were stimulated with plate-bound ICs at 10 µg/ml opsonized with soluble C5b-9 at 2.5 µg/ml for each 2.5 X 10 5 cell in the presence of plate-bound anti-CD3 at 0.25 µg/ml (eBioscience, clone OKT3).
Positive controls cells received 1 µg/ml of anti-CD28 (BD biosciences, clone 28.2). All studies were performed in the presence of anti-CD3, unless specified. Cells were polarized in the presence of IL-1b, IL-6, TGF1-b, and IL-23 as reported earlier [17] . For inhibition experiments, cells were treated with 10nM of P505 for sixty minutes, a Syk inhibitor (product no. PRT06207, Selleckchem)
prior to activation and were cultured in the presence of P505. Cells were activated with platebound ICs for 48 h in the presence of IL-2 (20 IU/ml) medium (Peprotech). Post 48 h, cells were again re-stimulated and processed for staining at 96 h.
Flow cytometry analysis
Multicolor flow staining was performed immediately after purifying the PBMCs. Cells were stained using anti-human CD4 PE-Cy7 (RPA-T4), anti-human CD4 PE eFluor 610 (RPA-T4), anti-human pSyk-PE (moch1a), anti-human ICOS-APC eFluor780 (1SA-3), anti-human-PD1-PE-Cy7 (eBio J105), anti-human CXCR5 eFluor 450 (MUSBEE), all from eBiosciences. Other antibodies used anti-human Bcl6-PE-CF594 (K112-91, anti-human IL-17A-APC-R700 (N49-553), anti-IL-21-BV421
(3A3-N2.1), anti-human IFN-g-BV711 (B27), anti-human CXCR3-BV711 (1C6/CXCR3) were purchased from BD Biosciences. Another anti-human IFN-g-APC (4S.B3) was purchased from
Biolegend. ICs were labeled using Alexa Fluor 488 5-TFP ester (A3005) from Molecular Probes.
The ICs conjugates were in the range of 23 to 30 µM fluorochrome to-protein ratio. Purification and conjugation was performed as described previously [16, 18] . All conjugates were titrated and flow compensation was done using isotype controls. 
RNA-seq transcriptome analysis
Purified were differentiated using a mixture of four cytokines as described in previous section. RNA was purified from naïve CD4 + T-cells activated with anti-CD3 (0.25 µg/ml) + anti-CD28 (2.0 µg/ml) or anti-CD3 + ICs opsonized with C5b-9 using an RNA purification kit from Clontech laboratories. A total of 20 ng of RNA was used to generate the RNA-seq libraries using the Ion AmpliSeq
Transcriptome Human Gene Expression Kit as per manufacturers recommendations. The libraries were indexed using the primers from ABI. We then sequenced these synthesized libraries using the Ion Torrent Sequencer in the Genomic Core (Saint Louis University School of Medicine).
Statistical analysis and differential expression was performed for RNA transcripts using R and subjected to GO annotation analysis using R. Heat maps and cluster analysis was performed using CIMinor (nci.nih.gov). Reads per million from the RNA-seq data was used as input for the generation of the heat maps. Total normalized reads obtained from FcgRIIIa or CD28 cosignaling was divided with reads obtained from untreated paired sample of the same subject. Relative fold change was used for generating heat maps. Gene expression dot plots were generated in R.
Results
In SLE, ICs bound cells express T FH markers and show phopshorylated Syk figure 1f ). These findings are consistent with our earlier report, where we observed IFN-g production from FcgRIIIa cosignaling in activated human naïve CD4 + T cells [16, 17] . Blood memory T FH 1 cells are marked by the presence of chemokine receptor CXCR3 + and IFN-g production [22] . Circulating T FH 1 cells correlate with the generaton of protective antibody repertoire [22, 23] . To examine the participation of FcgRIIIa cosignaling in IFN-g production in T FH 1 cells, we analyzed CXCR3 expression and IFN-g production in pSyk + cells.
These results indicated that the CXCR3 + IFN-g + double positive cells show strong correlation with the CXCXR3 + pSyk + cells, r = 0.910 (figure 1i). These cells likely represent memory effector population, since lack of CXCR3 expression marks T central memory cells [5] . Post influemza vaccination CXCR3 + T FH cells were able to induce memory B cells to differentiate into antibody producing plasma cells [23] . Changes in the frequency of T FH 1 cells show association with disease activity [24] . In two patients, we observed cells that produced CXCR3 but did not show pSyk and produced IFN-g ( figure S2 ). These results, thus suggest that for FcgRIIIa-pSyk cosignaling possibly does not contribute to the CXCR3 expression observed in blood T FH 1 like cells. MicroRNAs regulate CD4 + T cell differentiation [31, 32] . miR-155, miR-146a, as well as miR-17~92
cluster (miR-17 is part of this cluster) regulate the development of T FH cells [4, 33] . To examine the participation of miRNAs, we examined and compared the levels of miRNAs RNA-transcripts from FcgRIIIa costimulation and compared them with CD28 costimulation. Hierarchical cluster analysis showed upregulation of several key miRNAs from FcgRIIIa costimulation, such as miR-155 (MIR155HG) (host gene, HG), miR-Let 7B (MIRLET7BHG), miR-17HG, and miR-3907. These
RNAs were prominently overexpressed in three of four patients analyzed ( figure 5C ). miR-155 was upregulated in two of four subjects analyzed. MiR-155 regulates IRAK3, and IKKe, which then via IRF3 induces type I IFNs [34] . miR-155 also promotes T FH cells accumulation during chronic lowgrade inflammation [35] . A large subset of miRNAs and lincRNAs were modulated by FcgRIIIa costimulation vs. CD28 in naïve CD4 + T cells ( figure S4 ). miR-3907, which is a known risk allele (GWAS study) was upregulated upon FcgRIIIa costimulation ( figure 5C ) [36] . miR-22 by influencing HDAC4 regulate T cell differentiation. miR-490 modulates cell growth and miR-548 targets IFNgR1.
miR-548I1-3 associates with RNA-induced silencing complex (RISC) and regulates translation imitation. These cumulative data suggest that the FcgRIIIa cosignaling via miRNAs, regulates the T FH differentiation. Both HOTTIP and HOTAIR were also upregulated. These miRNAs are shown to regulate several key autoimmune processes.
Our data from both direct in vivo and in vitro analysis provide a strong evidence for the participation of FcgRIIIa cosignaling the generation of T FH like cells, which will form cytoconjugates with B cells and trigger the generation of autoreactive B cells ( figure 6 ).
Discussion
Circulating blood T FH cells are increased in SLE and their number correlate with disease activity [24, 37] . Thus, it is important to identify the signals that contribute to their expansion and characterize their phenotype in SLE [12] . Abundant IC formation and T FH cells contribute to the autoimmune pathologies and infections [5, 38] .
Increased frequency of T FH cells are observed in the peripheral blood of SLE patients [6, 21, 37] . T FH cell numbers correlate with an increase in autoantibody titers and tissue damage [39] . In addition to a strong TCR signal, CD28 cosignaling is required for the T FH development [40] .
However, the blockade of CD28 cosignaling in later stages of differentiation does not block the generation of T FH cells [41] . This suggests the role of alternate activating co-signals in T FH differentiation. In autoimmunity, signals other than CD28 drive the development of effector CD4 + T cells [42] . Our results suggest that the FcgRIIIa-pSyk is one of this unrecognized cosignal that can substitute the CD28 cosignaling in the T FH development. In vivo FcgRIIIa + -pSyk + CD4 + T cells were identified, which produce IL-21 and express Bcl6. Bcl6 + cells that produce IL-21, a T FH cytokine show pSyk both in vivo and in vitro. Bcl6 expression has been reported in the circulating blood T FH cells in SLE [6, 21] . These findings are contrary to previous report, where in circulating T FH cells during HIV infection did not express Bcl6 [5] . It is proposed that low or lack of Bcl6 in circulating T FH is a marker of the quiescent memory cells. It is somewhat surprising that Bcl6, a marker for GC T FH cells is absent from circulating T FH cells in viral infection, where one would expect activated cells. Bcl6 is necessary for GC reaction. The circulating T FH cells should have the capacity to develop ectoid GCs, which are observed in the nephritic kidney and arthritic synovium. We also observed two populations of PD1 expressing cells, where pSyk + cells produced lower amount of PD1. We are not clear, how pSyk participate in downregulating the PD1. We hypothesize that the FcgRIIIa-pSyk cosignal by downregulating PD1 favors cellular activation. PD1 targeted therapies provide significant clinical benefit in some patients, while temporary, partial or no clinical benefit in other patients [43] .
Our in vitro data show that the FcgRIIIa-pSyk cosignaling in a milieu of four-cytokines IL1-b, IL-6, IL-23, and TGF1-b, results in the development of T FH like cells [44] . These cells produce IFN-g, IL-17A and IL-21 [17, 44] . In humans, IL-23 and TGF1b drives the early differentiation of T FH cells, and cytokines IL-6, IL-21, and IL-1b support this process. FcgRIIIa costimulation upregulates GM-CSF and Csf2 RNA transcripts in naïve CD4 + T cells, genes normally associated with terminally differentiated T H 17 pathogenic phenotype [17] . It is ambiguous which T FH cell type is important for B cell help. One report showed that the T FH 17 are efficient B cell helper for isotype class switching [1] . Another report suggested a role for blood T FH 1 cells in SLE pathology [24] . Our results suggest a role of FcgRIIIa costimulation in the development of pathogenic CD4 + T cells and further authentication of T FH subtypes in SLE is needed for therapeutic intervention. Excessive production of IL-21 from FcgRIIIa-pSyk cosignaling in T FH cells could override their inhibition by the T FR cells [27] .
Our results also suggest a role for cosynergistic signaling from FcgRIIIa-pSyk and TLR9 in T FH expansion (figure 4). A cosynergistic signaling between FcRs and NA-TLRs is observed in B cells, where DNA/RNA ICs engage BCR/FcRs and/or TLRs [29] . A coordinated signaling from BCR and TLR contributes to the positive selection of self-reactive B cells [45] . Chromatin-IgG complexes activate B cells by the dual engagement of IgM and TLRs [46] . In CD4 + T cells, DNA/RNA containing ICs by engaging FcgRIIIa and TLR9 could thus enhance T FH development [18] . CpG 2006 bound to TLR9 on T cell surface and MyD88 protein co-immunoprecipitates with FcgRIIIa protein, which suggest a coordinated signaling in CD4 + T cells [18] . In B cells, joint signaling from ITAM (in FcRs) and MyD88 ( in NA-TLRs) is distinct, compared to individual signaling from either ITAM or MyD88 [29] .
ICs are composed of large number of antigenic peptides [47] . Both FDC and/or GC B cells
retain ICs on the cell surface, which fulfill the antigenic requirement for T FH development in GC reaction. Our data suggest that the ICs bound to T FH cells could achieve two objectives, first they could contribute to the fulfillment of excessive antigenic requirement of T FH cells, and second they may provide an additional positive costimulatory signal. The additive positive costimulation by FcgRIIIa will contribute to TCR signal strength [16, 18] . A strong TCR signal is a prerequisite for the development of T FH cells [40] . FcgRIIIa engagement by the ICs phosphorylates TCR signaling proteins [13, 16] . Mice studies have shown that the T FH response is dictated by the amount of antigen, which correlate with the magnitude of GC B cell response [48] . The antigen presentation by GC B cells, and not the unique B cell derived signal is required for the development of T FH cells [7] . A role for ICs in GC dynamics is also supported by the abundance of SCS macrophages in GCs, which retain and recycle ICs to cell surface and have poor phagocytic function [49] . Our in vitro experiments mimic some of these interactions and confirm a role for ICs in T FH generation.
RNA-seq data revealed that FcgRIIIa engagement by ICs influence the expression of several key transcription factors required for T FH development (figure 5). We observed the overexpression of GPCR signaling, FOXO and c-MAF pathway transcripts. Transcriptional regulators of FOXO and c-MAF pathways modulates T FH responses [4] . PI3K signals via Akt promote T FH differentiation.
PI3-Akt signal phosphorylates FOXO, which leads to its exportation and degradation. This removes Bcl6 repression, thus promoting T FH generation [50] . ICOS expressing cells are enhanced in SLE and these patients show more severe disease activity [37] .
The miRNAs play a role in the development of CD4 + T E cells. Our data provide an evidence that the FcgRIIIa mediated costimulation influences the CD4 + T cell responses by modulating the expression of miRNAs ( figure 5 ). The miR-17~92 cluster, miR-146a, and miR-155 regulate T FH development [4, 51] . Target genes of miR-17~92 have been identified to play an important role in the T FH biology and IFN-g production [52] . This cluster 17-92 is a master switch, which participate in T H 1 and T H 17 development [32] . The miR-155 and miR-146a have opposing roles in controlling T FH differentiation [35] . miR-155 also enhances GC B cell differentiation and cytokine production.
Several of these miRNAs regulate ICOS mediated responses. Upregulation of miR-1307 from
FcgRIIIa-pSyk cosignaling suggest a mechanistic role for FcgRIIIa costimulation in SLE pathology via miR-1307 regulation [36] . Further validation of this data will be useful in recognizing events that contribute to autoimmunity. 
